CMBA
NARI

C.M. Bidwell & Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History

C.M. Bidwell & Associates’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-540
Closed -$49K – 622
2021
Q4 		$49K Buy
+540
New +$46.3K 0.03% 299

Other funds holding NARI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

C.M. Bidwell & Associates's NARI Position: Q1 2022 in Review

C.M. Bidwell & Associates sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2022, closing a stake of 540 shares — an estimated $49K sold.

C.M. Bidwell & Associates first reported a position in NARI in Q4 2021 and held it in 1 quarter. The position peaked at $49K in Q4 2021. 214 funds tracked by Wall St. Rank hold NARI as of Q1 2022.

  • C.M. Bidwell & Associates reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 540 Inari Medical, Inc. Common Stock shares in Q1 2022, an estimated $49K.
  • C.M. Bidwell & Associates first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Inari Medical, Inc. Common Stock position peaked at $49K in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.